An IL-10-Fc fusion protein acts through IL-10 receptors on T cells to specifically enhance OXPHOS, proliferation and cytotoxicity in this subset, thereby reversing exhaustion and enhancing anti-tumor response (108, 109). The gene discussed is IL10; the disease is neoplasm.